All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

118

Reset

118 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • KJ101Phase 21 trial

    Shanghai Bao Pharmaceuticals Co., Ltd. · Burn, Burn Wounds - Partial Thickness (2nd Degree)

  • LEO 138559LEO 138559 is also called "temtokibart"Phase 21 trial

    LEO Pharma · Atopic Dermatitis

  • LY03015LPM3770164 sustained releasePhase 21 trial

    Luye Pharma Group Ltd. · Tardive Dyskinesia (TD)

  • N17350Phase 21 trial

    Onchilles Pharma Inc · Neoplasms, Solid Tumor, Breast Neoplasms, Triple-Negative, Squamous Cell Carcinoma of Skin

  • NBI-1065890Phase 21 trial

    Neurocrine Biosciences · Tardive Dyskinesia

  • OBX-115Phase 21 trial

    Obsidian Therapeutics, Inc. · Tumor Skin, Metastatic Melanoma, Melanoma

  • PF-07264660Phase 21 trial

    Pfizer · Atopic Dermatitis

  • PF-08049820Phase 21 trial

    Pfizer · Atopic Dermatitis, Eczema, Atopic

  • PN-101Phase 21 trial

    Paean Biotechnology Inc. · Polymyositis, Dermatomyositis

  • SIM0278Phase 21 trial

    Jiangsu Simcere Pharmaceutical Co., Ltd. · Atopic Dermatitis (AD)

  • SKX-16Luliconazole 10%Phase 21 trial

    SATO Pharmaceutical Co., Ltd. · Onychomycosis of Toenails

  • STMC-103HPhase 21 trial

    Siolta Therapeutics, Inc. · Atopic Dermatitis, Type 1 Hypersensitivity

  • TAVO101Phase 21 trial

    Tavotek Biotherapeutics · Atopic Dermatitis

  • TCP-25Phase 21 trial

    Xinnate AB · Epidermolysis Bullosa (EB), Dystrophic Epidermolysis Bullosa, Junctional Epidermolysis Bullosa

  • TRIV-509Phase 21 trial

    Triveni Bio · Atopic Dermatitis

  • TRIV-573Phase 21 trial

    Triveni Bio · Atopic Dermatitis

  • UCB1381Phase 21 trial

    UCB · Atopic Dermatitis

  • YR001Phase 21 trial

    Hangzhou Yirui Pharmaceutical Technology Co., Ltd · Atopic Dermatitis

NewerPage 3 of 3

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.